Adenocyte

Private

JerusalemHealthcare & Life Scienceshttps://www.adenocyte.com/

Last Round

Early Funding

May 26, 2026

Company Overview

Adenocyte is a medical technology company that has developed a platform for the early detection of adenocarcinoma and its precursors.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Precision Medicine, Medical Imaging

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription, Government Contracts

AI Layer

Non-AI

Keywords

pancreatic cancer detectionLINFUearly cancer detectioncytological samplingminimally invasive diagnosticslow intensity non-focused ultrasoundcancer screeningmicrobubble enhanced ultrasoundliquid biopsyadenocarcinoma detectionultrasound diagnosticsprecancerous detectionmedical devicemedtechCPT code reimbursementgastroenterology tools

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Adenocyte Comparables

Compare Adenocyte with similar companies based on industry and business-model similarity.

Adenocyte comparables — related companies by embedding similarity
Company	Similarity	Market Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Adenocyte Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Early Funding	May 26, 2026

View all Funding Rounds

Adenocyte Investors

Notable investors and investment history

Adenocyte investors
Investor	Rounds
Israel Innovation Authority	Grant
iGan Partners	Early Funding

View all Investors

Adenocyte Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Adenocyte Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Adenocyte's valuation, stock price, and market status.

Firmographic Details

HeadquartersJerusalem

Employee Range1

Year Founded2018

Last FundingMay 26, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.